Thomas McLean to Antineoplastic Agents
This is a "connection" page, showing publications Thomas McLean has written about Antineoplastic Agents.
Connection Strength
1.424
-
Dupuis LL, Tamura RN, Kelly KM, Krischer JP, Langevin AM, Chen L, Kolb EA, Ullrich NJ, Sahler OJZ, Hendershot E, Stratton A, Sung L, McLean TW. Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy. Pediatr Blood Cancer. 2019 04; 66(4):e27584.
Score: 0.475
-
Dupuis LL, Kelly KM, Krischer JP, Langevin AM, Tamura RN, Xu P, Chen L, Kolb EA, Ullrich NJ, Sahler OJZ, Hendershot E, Stratton A, Sung L, McLean TW. Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial. Cancer. 2018 03 15; 124(6):1188-1196.
Score: 0.443
-
Levy M, Wofford MM, Powell BL, McLean TW. Hyperleukocytosis from arsenic trioxide. Pediatr Blood Cancer. 2008 Jun; 50(6):1265-7.
Score: 0.229
-
Jones E, Isom S, Kemper KJ, McLean TW. Acupressure for chemotherapy-associated nausea and vomiting in children. J Soc Integr Oncol. 2008; 6(4):141-5.
Score: 0.222
-
McLean TW. Medulloblastomas and central nervous system primitive neuroectodermal tumors. Curr Treat Options Oncol. 2003 Dec; 4(6):499-508.
Score: 0.042
-
McDonald M, McLean T, Belhorn T, Smith SV, Fordham LA, Woods C, Blatt J. Thymic carcinoma in a child with HIV infection. Pediatr Blood Cancer. 2007 Dec; 49(7):1004-7.
Score: 0.014